CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


We found 7001 result(s)

caplacizumab (Cablivi)

Last Updated: September 25, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Complete
  • Submission Type: New

Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes

Last Updated: September 24, 2020
Result type: Reports
Product Line: Technology Review

Devices to monitor glycemia have recently evolved to reduce the number of steps required as compared with the traditional approach — i.e., the self-monitoring of blood glucose using test strips. One of these devices is FreeStyle Libre, which uses a technology called a flash glucose monitoring system (FGMS). An FGMS enables patients to measure th...

  • Project Number: HO0009-000

satralizumab (Enspryng)

Last Updated: September 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: satralizumab
Indications: Neuromyelitis optica spectrum disorder

  • Brand Name: Enspryng
  • Manufacturer: Hoffmann-La Roche Limited
  • Project Number: SR0663-000
  • Project Status: Pending
  • Submission Type: New